Motilal Oswal recommends buying the Max Healthcare Institute stock, setting a target price of Rs 1,380. The brokerage projects strong growth, driven by the company’s plan to triple bed capacity in the next five years. Max Healthcare reported a rise in total income and net profit for the recent quarter.